Whilst green poop on Mounjaro is not listed as a specific adverse effect, it reflects normal physiological responses to medication-induced changes in gut motility and is rarely a sign of serious pathology
Protects against oxidative stress and free radicals
(2024, September) Retatrutide is a novel triple-agonist targeting GLP-1, GIP, and glucagon receptors, showing in phase 2 trials that it can deliver remarkably large weight losses (up to ~24% over 48 weeks in people with obesity) along with strong improvements in HbA1c, lipid profiles, liver fat (in NAFLD), insulin sensitivity, and other cardiometabolic markers
Record-Breaking Weight Loss in Trials Triple Hormone Targeting Rapid Fat Loss in the First Months Visceral Fat Meltdown Improves Insulin Sensitivity in a Big Way Longevity Potential Appetite Control That Actually Lasts All Day Possible Anti-Fibrotic & Liver Benefits Certificate Of Analysis by 3rd Party Lab When it comes to peptides, independent verification matters